The bioinformatics services market is expanding rapidly as genomics and life science research increasingly rely on computational tools to interpret complex biological data. These services encompass data analysis for genomics, proteomics, drug discovery, molecular modeling, and clinical trials. Key drivers include the surge in next-generation sequencing projects, demand for personalized medicine, collaboration between pharma and biotech firms, and a growing need for AI-powered analytics. As research sophistication grows and data volumes swell, bioinformatics service providers play a crucial role in turning raw data into actionable insights, supporting drug development, diagnostics, and precision healthcare.
According to Fortune Business Insights, the global bioinformatics services market was valued at USD 5.34 billion in 2024. The market is projected to grow from USD 6.51 billion in 2025 to USD 18.13 billion by 2032, exhibiting a CAGR of 15.8% during the forecast period. In 2024, North America dominated the bioinformatics services market with a market share of 46.25%.
📌 Top Companies Leading the Market
- Illumina, Inc. (U.S.)
- QIAGEN (Netherlands)
- CD Genomics (U.S.)
- Excelra (U.S.)
- Creative Proteomics (U.S.)
- Fios Genomics (U.K.)
- Thermo Fisher Scientific Inc. (U.S.)
- Eurofins Scientific (Luxembourg)
- Psomagen (U.S.)
Key Industry Development – June 2023
Psomagen expanded its bioinformatics offering by integrating the Pacific Bioscience Revio system. This platform supports whole-genome/exome sequencing, bulk and single-cell RNA‑seq, microbiome analysis, Olink proteomics, and more—enhancing precision and service breadth .
Market Drivers & Restraints
🚀 Key Drivers
- Growth in Genomics/Proteomics Research: Increased investment in clinical research and drug discovery is fueling demand for bioinformatics solutions .
- Cloud-Based Bioinformatics: Adoption of cloud platforms reduces costs and improves access to clinical data, fueling expansion .
- Personalized Medicine & Vaccinology: Bioinformatics plays a crucial role in tailoring treatments and vaccines, thanks to data‑driven insights .
- COVID-19 Impact: Surge in genomic sequencing and data analysis during the pandemic accelerated market growth .
⚠️ Market Restraints
- High Cost of Technology: Advanced sequencing tools and analytics services present a substantial financial barrier .
- Complex Data Management: Handling vast, multi-dimensional datasets requires specialized skills and infrastructure .
- Talent Shortage: Scarcity of qualified bioinformaticians in many regions slows market uptake .
Market Report Coverage
The comprehensive report by Fortune Business Insights includes:
- Market size and multi-year forecasts
- Segmentation by service type, application, and end user
- Regional analyses across North America, Europe, Asia‑Pacific, Latin America, and MEA
- Technological trends and pandemic impact
- Competitive landscape and key developments
Competitive Landscape
The market features strong competition among global leaders like Illumina, QIAGEN, Thermo Fisher, and Eurofins, alongside agile providers like CD Genomics, Excelra, Creative Proteomics, Fios Genomics, and Psomagen. Psomagen’s integration of the Revio system underscores the strategic efforts to broaden service offerings .
Market Segments
In 2024, the genomics segment led the market, driven by government research grants, academic initiatives, and demand for high-throughput sequencing .
Regional Insights
- North America: Held 46.25% market share in 2024 (~USD 2.47 billion), thanks to advanced infrastructure and biotech R&D .
- Europe and Asia‑Pacific: Also significant, with Europe supported by institutional funding and APAC showing fastest regional growth .
- Latin America, MEA: Experienced steady uptake, led by expanding research capabilities .
Explore the full research report with detailed insights and TOC:https://www.fortunebusinessinsights.com/bioinformatics-services-market-109496
Future Market Scope
The future of bioinformatics services will be shaped by:
- AI & Machine Learning Integration: Deeper data insights and faster analytics for complex biological projects .
- Cloud and Big‑Data Platforms: More scalable, secure, and accessible services for clients of all sizes .
- Personalized Medicine: As targeted therapies and vaccines grow, demand for bioinformatics services will increase .
- Multi-Omics & Blockchain: Integration of genomics, proteomics, metabolomics and secure data sharing technologies .
Conclusion
The bioinformatics services market is on track for remarkable growth—a market expanding from USD 5.34 billion in 2024 to USD 18.13 billion by 2032. Anchored by technological innovation, genomic research trends, and digital transformation, it offers vast opportunities for stakeholders across healthcare, agriculture, biotechnology, and beyond. Established leaders and nimble newcomers alike are poised to benefit from this exciting trajectory.
About Us:
Fortune Business Insights provides expert corporate analysis and accurate data, enabling businesses of all sizes to make timely decisions. We offer customized solutions tailored to each client’s needs, helping them address unique challenges. Our goal is to empower clients with holistic market intelligence and offer granular insights into the market they operate in.
Our reports are a blend of quantitative and qualitative analysis, aimed at helping businesses achieve sustainable growth. Our experienced analysts and consultants use leading research methodologies to provide comprehensive market assessments enriched with relevant data.
At Fortune Business Insights, we aim to highlight growth opportunities for our clients, offering insights and recommendations that help them navigate technological and market changes. Our consulting services are designed to help companies uncover hidden opportunities and address competitive challenges.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA: +1 833 909 2966 (Toll-Free),
United Kingdom: +44 808 502 0280 (Toll-Free),
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
